Immune Complexes and the Risk of CVD in Type 1 Diabetes

We investigated whether the composition of modified forms of LDL in circulating immune complexes (LDL-ICs) was associated with cardiovascular disease (CVD) outcomes, including any CVD, major adverse cardiac and cerebrovascular events (MACCE), myocardial infarction (MI), and coronary artery disease,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes
Hlavní autoři: Lopes-Virella, Maria F., Bebu, Ionut, Hunt, Kelly J., Virella, Gabriel, Baker, Nathaniel L., Braffett, Barbara, Gao, Xiaoyu, Lachin, John M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2019
Témata:
Complications
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702641/
https://ncbi.nlm.nih.gov/pubmed/31217176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0358
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky